Related Experiment Video
Updated: Apr 30, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Genetic testing in bleeding disorders
C de Brasi1, O El-Maarri, D J Perry
1Instituto de Medicina Experimental (IMEX), CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina; Instituto de Investigaciones Hematologicas Mariano R Castex, Academia Nacional de Medicina, Buenos Aires, Argentina.
Molecular genetic analysis in haemophilia families identifies causative mutations. This knowledge aids patient care, inhibitor risk assessment, and carrier/prenatal diagnosis for relatives.
Area of Science:
- Medical Genetics
- Molecular Biology
- Haematology
Background:
- Haemophilia is a genetic bleeding disorder requiring precise molecular diagnostics.
- Identifying causative mutations is crucial for patient management and family screening.
Purpose of the Study:
- To review advances in understanding and detecting haemophilia-causing mutations.
- To highlight the importance of molecular genetic analysis in haemophilia families.
Main Methods:
- Review of recent scientific literature on haemophilia mutations.
- Discussion of mutation detection methodologies.
- Emphasis on standardized reporting and quality assessment.
Main Results:
- Mutation identification provides critical data for affected males regarding inhibitor risk and assay discrepancies.
- Familial mutation knowledge enables accurate carrier status determination and prenatal diagnosis for female relatives.
- Advances in understanding and detecting haemophilia mutations are continuously emerging.
Conclusions:
- Molecular genetic analysis is essential for comprehensive haemophilia care.
- Accurate mutation identification and reporting improve patient outcomes and family planning.
- External quality assessment ensures reliable and informative genetic testing in haemophilia.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

